The U.S. spends $200 billion dollars on cancer care yet reports mortality rates higher than so many other high-income countries. Experts hoped this latest study would provide an answer.
CAR-T cell therapy is not new, but a study published in the journal Nature found solid evidence that the treatment not only works quickly but appears to be a permanent cure for patients diagnosed with certain blood cancers, such as leukemia.The U.S. spends the most on cancer care than any other country, so it would stand to reason that it would also report the lowest rates of mortality associated with the disease. found that while the U.S.
The other 22 countries that were studied spent only $300 per person per year on average. Researchers found that six countries including Finland, Iceland, Japan, Australia, South Korea and Switzerland reported lower mortality rates despite spending less on treatment for the disease. said Ryan Chow "Countries that spend more on cancer care, do not necessarily have better cancer outcomes," Chow added.